4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0000950170-25-045396
Chief Medical Officer sold 6,836 shares at $6.74 ($46,075)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Karlin Daniel Chief Medical Officer | 2025-03-25 | Sale 10b5-1 | −6,836 | $6.74 | $46,075 | 446,177 | D |
| Open-market sales · 6,836 sh · avg $6.74 · $46,075 | |||||||
Loading xslF345X05/ownership.xml…